Analysts Recommendations General Motors Company(NYSE:GM): Puma Biotechnology Inc(NASDAQ:PBYI)

0
1

General Motors Company (GM) will report its next earnings on Jan 28 BMO. The company reported the earnings of $1.72/Share in the last quarter where the estimated EPS by analysts was $1.31/share. The difference between the expected and actual EPS was $0.41/share, which represents an Earnings surprise of 31.3%.

Many analysts are providing their Estimated Earnings analysis for General Motors Company and for the current quarter 13 analysts have projected that the stock could give an Average Earnings estimate of $0.08/share. These analysts have also projected a Low Estimate of $-0.12/share and a High Estimate of $0.29/share.

In case of Revenue Estimates, 9 analysts have provided their consensus Average Revenue Estimates for General Motors Company as 29.78 Billion. According to these analysts, the Low Revenue Estimate for General Motors Company is 25.97 Billion and the High Revenue Estimate is 36.3 Billion. The company had Year Ago Sales of 38.4 Billion.

Some buy side analysts are also providing their Analysis on General Motors Company, where 4 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.05 and Average Volume (3 months) is 9.18 million. The company’s P/E (price to earnings) ratio is 5.78 and Forward P/E ratio of 5.43.

The company shows its Return on Assets (ROA) value of 3.8%. The Return on Equity (ROE) value stands at 21.1%. While it’s Return on Investment (ROI) value is 2.6%.

While looking at the Stock’s Performance, General Motors Company currently shows a Weekly Performance of -4.6%, where Monthly Performance is -1.31%, Quarterly performance is -0.03%, 6 Months performance is -11.63% and yearly performance percentage is -0.23%. Year to Date performance value (YTD perf) value is -5.33%. The Stock currently has a Weekly Volatility of 2.76% and Monthly Volatility of 1.85%.

Puma Biotechnology Inc (PBYI) will report its next earnings on Feb 05 AMC. The company reported the earnings of $-0.44/Share in the last quarter where the estimated EPS by analysts was $-0.71/share. The difference between the expected and actual EPS was $0.27/share, which represents an Earnings surprise of 38%.

Many analysts are providing their Estimated Earnings analysis for Puma Biotechnology Inc and for the current quarter 10 analysts have projected that the stock could give an Average Earnings estimate of $-0.49/share. These analysts have also projected a Low Estimate of $-0.67/share and a High Estimate of $-0.33/share.

In case of Revenue Estimates, 8 analysts have provided their consensus Average Revenue Estimates for Puma Biotechnology Inc as 59.53 Million. According to these analysts, the Low Revenue Estimate for Puma Biotechnology Inc is 56 Million and the High Revenue Estimate is 66.26 Million. The company had Year Ago Sales of 71.1 Million.

Some buy side analysts are also providing their Analysis on Puma Biotechnology Inc, where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 1.08 and Average Volume (3 months) is 1.7 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -35.8%. The Return on Equity (ROE) value stands at -325.9%. While it’s Return on Investment (ROI) value is -55.7%.

While looking at the Stock’s Performance, Puma Biotechnology Inc currently shows a Weekly Performance of 0.84%, where Monthly Performance is -0.82%, Quarterly performance is 16.14%, 6 Months performance is -27.79% and yearly performance percentage is -66.32%. Year to Date performance value (YTD perf) value is -3.77%. The Stock currently has a Weekly Volatility of 7.88% and Monthly Volatility of 7.75%.

SHARE